Malaria biology and disease pathogenesis: insights for new treatments

LH Miller, HC Ackerman, X Su, TE Wellems - Nature medicine, 2013 - nature.com
Plasmodium falciparum malaria, an infectious disease caused by a parasitic protozoan,
claims the lives of nearly a million children each year in Africa alone and is a top public …

[HTML][HTML] Mechanisms of disease: pulmonary arterial hypertension

RT Schermuly, HA Ghofrani, MR Wilkins… - Nature Reviews …, 2011 - nature.com
Our understanding of, and approach to, pulmonary arterial hypertension has undergone a
paradigm shift in the past decade. Once a condition thought to be dominated by increased …

Protein arginine methylation in mammals: who, what, and why

MT Bedford, SG Clarke - Molecular cell, 2009 - cell.com
The covalent marking of proteins by methyl group addition to arginine residues can promote
their recognition by binding partners or can modulate their biological activity. A small family …

Molecular pathogenesis of pulmonary arterial hypertension

M Rabinovitch - The Journal of clinical investigation, 2012 - Am Soc Clin Investig
Recent clinical and experimental studies are redefining the cellular and molecular bases of
pulmonary arterial hypertension (PAH). The genetic abnormalities first identified in …

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies

SL Archer, EK Weir, MR Wilkins - Circulation, 2010 - Am Heart Assoc
Pulmonary arterial hypertension (PAH) is a syndrome in which pulmonary arterial
obstruction increases pulmonary vascular resistance, which leads to right ventricular (RV) …

Molecular mechanisms underlying the activation of eNOS

I Fleming - Pflügers Archiv-European Journal of Physiology, 2010 - Springer
Endothelial cells situated at the interface between blood and the vessel wall play a crucial
role in controlling vascular tone and homeostasis, particularly in determining the expression …

eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues

JL Balligand, O Feron, C Dessy - Physiological reviews, 2009 - journals.physiology.org
Nitric oxide production in response to flow-dependent shear forces applied on the surface of
endothelial cells is a fundamental mechanism of regulation of vascular tone, peripheral …

Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine

YT Ghebremariam, P LePendu, JC Lee, DA Erlanson… - Circulation, 2013 - Am Heart Assoc
Background—Proton pump inhibitors (PPIs) are gastric acid–suppressing agents widely
prescribed for the treatment of gastroesophageal reflux disease. Recently, several studies in …

Nitric oxide deficiency in chronic kidney disease

C Baylis - American Journal of Physiology-Renal …, 2008 - journals.physiology.org
The overall production of nitric oxide (NO) is decreased in chronic kidney disease (CKD)
which contributes to cardiovascular events and further progression of kidney damage. There …

Asymmetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: a systematic review and meta-analysis of prospective …

S Schlesinger, SR Sonntag, W Lieb, R Maas - PloS one, 2016 - journals.plos.org
Background A growing number of studies linked elevated concentrations of circulating
asymmetric (ADMA) and symmetric (SDMA) dimethylarginine to mortality and cardiovascular …